Kate Kucharzyk is Cleaning Up at Work
Kate Kucharzyk is leading efforts to expand Battelle’s metagenomic and proteomics capabilities for environmental clients.
Behind the Study: Investigate the MPS Feasibility and Guidance Report
After an exhaustive 19-month research project, massively parallel sequencing is proven to generate robust, reliable, reproducible results.
3 Innovations Improving Safety Pharmacology Testing
Toxicology safety testing teams are under more pressure than ever. Here are three significant innovations helping tox teams achieve more success.
An Action-Packed End to Summer at Battelle
The end of August brings more than just a holiday weekend and reminders that fall is fast approaching. For Battelle, it meant a very busy week.
Bringing Down Barriers to Medical Countermeasure Development
To meet the need for new vaccines for chemical & biological weapons, federal agencies & private companies must work together to overcome barriers.
What the MPS Feasibility Report Means for Forensic Science Today
Massively Parallel Sequencing has been the talk of DNA scientists, but now it’s closer than ever to becoming a valid asset for law enforcement.
Sign Up for Battelle Updates
Follow along with the latest news, announcement and updates from our Battelle community of solvers.